Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic bone marrow transplantation vs chemotherapy for the treatment of childhood acute lymphoblastic leukaemia in second complete remission (revisited 10 years on).
Torres A, Alvarez MA, Sánchez J, Flores R, Martinez F, Gómez P, Rojas R, Herrera C, García JM, Andrés P, Velasco F, Serrano J, Román J, Rodriguez A, Martin C, Tabares S, Rodriguez JM, Parody R, Plaza E, León A, Romero R, Jean-Paul E, Prados D, Aljama R, Fernández A. Torres A, et al. Among authors: velasco f. Bone Marrow Transplant. 1999 Jun;23(12):1257-60. doi: 10.1038/sj.bmt.1701802. Bone Marrow Transplant. 1999. PMID: 10414912 Clinical Trial.
Comparison of bezafibrate versus lovastatin for lowering plasma insulin, fibrinogen, and plasminogen activator inhibitor-1 concentrations in hyperlipemic heart transplant patients.
Zambrana JL, Velasco F, Castro P, Concha M, Vallés F, Montilla P, Jimenéz-Perepérez JA, López-Miranda J, Pérez-Jiménez F. Zambrana JL, et al. Among authors: velasco f. Am J Cardiol. 1997 Oct 1;80(7):836-40. doi: 10.1016/s0002-9149(97)00532-8. Am J Cardiol. 1997. PMID: 9381994 Clinical Trial.
First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
Kreuz W, Escuriola Ettingshausen C, Vdovin V, Zozulya N, Plyushch O, Svirin P, Andreeva T, Bubanská E, Campos M, Benedik-Dolničar M, Jiménez-Yuste V, Kitanovski L, Klukowska A, Momot A, Osmulskaya N, Prieto M, Šalek SZ, Velasco F, Pavlova A, Oldenburg J, Knaub S, Jansen M, Belyanskaya L, Walter O; ObsITI study group; ObsITI committee. Kreuz W, et al. Among authors: velasco f. Haemophilia. 2016 Jan;22(1):87-95. doi: 10.1111/hae.12774. Epub 2015 Jul 23. Haemophilia. 2016. PMID: 26202305 Free article.
389 results